ConductScience.org, home

Paper41363115

Methylation-based signature to distinguish indolent and aggressive prostate cancer.

Liao M and 4 others. Biol Open, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Methylation-based signature to distinguish indolent and aggressive prostate cancer. Papers, record 41363115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41363115

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Methylation-based signature to distinguish indolent and aggressive prostate cancer.
PubMed
Journal
Biol Open
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-01-08
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liao MMuheng
2Webster JJace
3Ly AAmy
4Rozycki EEmily
5Maher CAChristopher Ahttps://orcid.org/0009-0005-1728-4614

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Prostatic NeoplasmsMajor topic
DNA MethylationMajor topic
Biomarkers, TumorMajor topic
Humans
Male
Prognosis
Epigenesis, Genetic
Gene Expression Regulation, Neoplastic
Neoplasm Grading
Disease Progression
Machine Learning
Computational Biology

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
W81XWH-18-2-0019PCRP Prostate Cancer Biorepository NetworkPubMed
Washington University in St Louis School of MedicinePubMed

Source PubMed

Download CSV of grants

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140063046Prostate Cancer: A Review.JAMA2025https://conductscience.org/library/papers/40063046PubMed
233079976Gleason Score Evolution and the Effect on Prostate Cancer Outcomes.Am J Clin Pathol2021https://conductscience.org/library/papers/33079976PubMed
325972926De novo identification of differentially methylated regions in the human genome.Epigenetics Chromatin2015https://conductscience.org/library/papers/25972926PubMed
437409096DNA methylation biomarkers distinguishing early-stage prostate cancer from benign prostatic hyperplasia.Prostate Int2023https://conductscience.org/library/papers/37409096PubMed
537953337Ensembl 2024.Nucleic Acids Res2024https://conductscience.org/library/papers/37953337PubMed
65948714Classification of prostatic carcinomas.Cancer Chemother Rep1966https://conductscience.org/library/papers/5948714PubMed
722212080Staging of prostate cancer.Histopathology2012https://conductscience.org/library/papers/22212080PubMed
839055653Role of actin-binding proteins in prostate cancer.Front Cell Dev Biol2024https://conductscience.org/library/papers/39055653PubMed
935437583Methylation Subtypes of Primary Prostate Cancer Predict Poor Prognosis.Cancer Epidemiol Biomarkers Prev2022https://conductscience.org/library/papers/35437583PubMed
1011942960Prognostic value of the Gleason score in prostate cancer.BJU Int2002https://conductscience.org/library/papers/11942960PubMed
1134140313Enzymatic methyl sequencing detects DNA methylation at single-base resolution from picograms of DNA.Genome Res2021https://conductscience.org/library/papers/34140313PubMed
1239817679Cancer statistics, 2025.CA Cancer J Clin2025https://conductscience.org/library/papers/39817679PubMed
1323299921APC gene hypermethylation and prostate cancer: a systematic review and meta-analysis.Eur J Hum Genet2013https://conductscience.org/library/papers/23299921PubMed
1437995683Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation.Cancer Cell2023https://conductscience.org/library/papers/37995683PubMed
1535719272Biomarkers for prostate cancer detection and risk stratification.Ther Adv Urol2022https://conductscience.org/library/papers/35719272PubMed
1639410867Prostate Cancer: A Review of Genetics, Current Biomarkers and Personalised Treatments.Cancer Rep (Hoboken)2024https://conductscience.org/library/papers/39410867PubMed
1739254403Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects.Asian J Androl2024https://conductscience.org/library/papers/39254403PubMed
1820808728Regularization Paths for Generalized Linear Models via Coordinate Descent.J Stat Softw2010https://conductscience.org/library/papers/20808728PubMed
1931640781Random forest-based modelling to detect biomarkers for prostate cancer progression.Clin Epigenetics2019https://conductscience.org/library/papers/31640781PubMed
2030729033Integrative analysis with expanded DNA methylation data reveals common key regulators and pathways in cancers.NPJ Genom Med2019https://conductscience.org/library/papers/30729033PubMed

See all 51 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41363115

GET https://conductscience.org/api/papers/v1/41363115/references?page=2